TNFSF10 and cancer: To address this question, an international team from Japan, France, and Singapore, led by Kumar Selvarajoo, has developed a spatiotemporal cellular automata model that tracks cancer proliferation in time and space, for cancers untreated and treated with potential drug targets (TRAIL and TRAIL plus BIS).